Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus
The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipid-lowering treatment and to B) assess the validity...
Gespeichert in:
| Veröffentlicht in: | Danish medical journal 2018-09, Vol.65 (9) |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 9 |
| container_start_page | |
| container_title | Danish medical journal |
| container_volume | 65 |
| creator | Madsen, Michael Moesmann Kærsvang, Lone Hansen, Anders Würgler Flink, Morten Nielsen, Henning K Hansen, Klavs Würgler |
| description | The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipid-lowering treatment and to B) assess the validity of the DADD indicator as a measure of quality of care.
A) A pop-up questionnaire enquiring about reasons for lack of treatment was added to the clinicians' data entry tool in the Central Denmark Region. B) The DADD indicator was compared on a per-clinic basis with the achieved median low-density lipoprotein (LDL) cholesterol level and with an internationally widely used indicator of lipid-lowering treatment quality.
A) A total of 3,491 patients were registered from 1 January 2013 to 28 February 2015. For 170 (62%) of 309 patients with an LDL level > 2.5 mmol/l who were not receiving lipid-lowering treatment, there was no "good" explanation for lacking treatment. Among 518 patients with an LDL level > 2.5 mmol/l despite lipid-lowering treatment, 259 (50%) did not receive high-intensity treatment. B) The DADD quality indicator was neither associated with the international quality indicator nor with the median per-clinic LDL level for T2DM patients.
A) We found substantial potential for improvement of lipid management among T2DM patients in Denmark by initiating and/or intensifying lipid-lowering treatment. B) The current DADD indicator is not a valid measure of lipid-lowering quality of care.
supported by the Rosa and Asta Jensen Foundation.
not relevant. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2100326745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2100326745</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-c580400926d53dec7a2c905efeeac6d57b7e1879ae8b797dfa3299e7481d0f293</originalsourceid><addsrcrecordid>eNo1kEtrwzAQhEWhNCHNXyg69mLQw7akYwl9QSCX9tSDkaVVUbEtR5Ip_vdVabqXhWVm-Hau0JaxuqmoomqD9il9kTItayUlN2jDCZVCtmSLPk5z9qNPOvsw4eDwedGDzyv2k_VG5xATdiHiwc_eVkP4huinT5wj6DzClH8teZ0BM2y97iFDwiMMJWJJt-ja6SHB_rJ36P3p8e3wUh1Pz6-Hh2M1M0pzZRpJakIUa23DLRihmVGkAQegTbmJXkDBVRpkL5SwTnOmFIhaUkscU3yH7v9y5xjOC6TclYdMgdAThCV1jBLCWSvqpkjvLtKlH8F2c_Sjjmv3Xwj_AYJWXXo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2100326745</pqid></control><display><type>article</type><title>Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Madsen, Michael Moesmann ; Kærsvang, Lone ; Hansen, Anders Würgler ; Flink, Morten ; Nielsen, Henning K ; Hansen, Klavs Würgler</creator><creatorcontrib>Madsen, Michael Moesmann ; Kærsvang, Lone ; Hansen, Anders Würgler ; Flink, Morten ; Nielsen, Henning K ; Hansen, Klavs Würgler</creatorcontrib><description>The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipid-lowering treatment and to B) assess the validity of the DADD indicator as a measure of quality of care.
A) A pop-up questionnaire enquiring about reasons for lack of treatment was added to the clinicians' data entry tool in the Central Denmark Region. B) The DADD indicator was compared on a per-clinic basis with the achieved median low-density lipoprotein (LDL) cholesterol level and with an internationally widely used indicator of lipid-lowering treatment quality.
A) A total of 3,491 patients were registered from 1 January 2013 to 28 February 2015. For 170 (62%) of 309 patients with an LDL level > 2.5 mmol/l who were not receiving lipid-lowering treatment, there was no "good" explanation for lacking treatment. Among 518 patients with an LDL level > 2.5 mmol/l despite lipid-lowering treatment, 259 (50%) did not receive high-intensity treatment. B) The DADD quality indicator was neither associated with the international quality indicator nor with the median per-clinic LDL level for T2DM patients.
A) We found substantial potential for improvement of lipid management among T2DM patients in Denmark by initiating and/or intensifying lipid-lowering treatment. B) The current DADD indicator is not a valid measure of lipid-lowering quality of care.
supported by the Rosa and Asta Jensen Foundation.
not relevant.</description><identifier>EISSN: 2245-1919</identifier><identifier>PMID: 30187860</identifier><language>eng</language><publisher>Denmark</publisher><subject>Aged ; Cholesterol, LDL - blood ; Denmark ; Diabetes Mellitus, Type 2 - complications ; Female ; Humans ; Hypercholesterolemia - drug therapy ; Hypolipidemic Agents - therapeutic use ; Male ; Middle Aged ; Quality Indicators, Health Care ; Retrospective Studies</subject><ispartof>Danish medical journal, 2018-09, Vol.65 (9)</ispartof><rights>Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30187860$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madsen, Michael Moesmann</creatorcontrib><creatorcontrib>Kærsvang, Lone</creatorcontrib><creatorcontrib>Hansen, Anders Würgler</creatorcontrib><creatorcontrib>Flink, Morten</creatorcontrib><creatorcontrib>Nielsen, Henning K</creatorcontrib><creatorcontrib>Hansen, Klavs Würgler</creatorcontrib><title>Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus</title><title>Danish medical journal</title><addtitle>Dan Med J</addtitle><description>The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipid-lowering treatment and to B) assess the validity of the DADD indicator as a measure of quality of care.
A) A pop-up questionnaire enquiring about reasons for lack of treatment was added to the clinicians' data entry tool in the Central Denmark Region. B) The DADD indicator was compared on a per-clinic basis with the achieved median low-density lipoprotein (LDL) cholesterol level and with an internationally widely used indicator of lipid-lowering treatment quality.
A) A total of 3,491 patients were registered from 1 January 2013 to 28 February 2015. For 170 (62%) of 309 patients with an LDL level > 2.5 mmol/l who were not receiving lipid-lowering treatment, there was no "good" explanation for lacking treatment. Among 518 patients with an LDL level > 2.5 mmol/l despite lipid-lowering treatment, 259 (50%) did not receive high-intensity treatment. B) The DADD quality indicator was neither associated with the international quality indicator nor with the median per-clinic LDL level for T2DM patients.
A) We found substantial potential for improvement of lipid management among T2DM patients in Denmark by initiating and/or intensifying lipid-lowering treatment. B) The current DADD indicator is not a valid measure of lipid-lowering quality of care.
supported by the Rosa and Asta Jensen Foundation.
not relevant.</description><subject>Aged</subject><subject>Cholesterol, LDL - blood</subject><subject>Denmark</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Female</subject><subject>Humans</subject><subject>Hypercholesterolemia - drug therapy</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Quality Indicators, Health Care</subject><subject>Retrospective Studies</subject><issn>2245-1919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtrwzAQhEWhNCHNXyg69mLQw7akYwl9QSCX9tSDkaVVUbEtR5Ip_vdVabqXhWVm-Hau0JaxuqmoomqD9il9kTItayUlN2jDCZVCtmSLPk5z9qNPOvsw4eDwedGDzyv2k_VG5xATdiHiwc_eVkP4huinT5wj6DzClH8teZ0BM2y97iFDwiMMJWJJt-ja6SHB_rJ36P3p8e3wUh1Pz6-Hh2M1M0pzZRpJakIUa23DLRihmVGkAQegTbmJXkDBVRpkL5SwTnOmFIhaUkscU3yH7v9y5xjOC6TclYdMgdAThCV1jBLCWSvqpkjvLtKlH8F2c_Sjjmv3Xwj_AYJWXXo</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Madsen, Michael Moesmann</creator><creator>Kærsvang, Lone</creator><creator>Hansen, Anders Würgler</creator><creator>Flink, Morten</creator><creator>Nielsen, Henning K</creator><creator>Hansen, Klavs Würgler</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20180901</creationdate><title>Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus</title><author>Madsen, Michael Moesmann ; Kærsvang, Lone ; Hansen, Anders Würgler ; Flink, Morten ; Nielsen, Henning K ; Hansen, Klavs Würgler</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-c580400926d53dec7a2c905efeeac6d57b7e1879ae8b797dfa3299e7481d0f293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Cholesterol, LDL - blood</topic><topic>Denmark</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Female</topic><topic>Humans</topic><topic>Hypercholesterolemia - drug therapy</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Quality Indicators, Health Care</topic><topic>Retrospective Studies</topic><toplevel>online_resources</toplevel><creatorcontrib>Madsen, Michael Moesmann</creatorcontrib><creatorcontrib>Kærsvang, Lone</creatorcontrib><creatorcontrib>Hansen, Anders Würgler</creatorcontrib><creatorcontrib>Flink, Morten</creatorcontrib><creatorcontrib>Nielsen, Henning K</creatorcontrib><creatorcontrib>Hansen, Klavs Würgler</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Danish medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madsen, Michael Moesmann</au><au>Kærsvang, Lone</au><au>Hansen, Anders Würgler</au><au>Flink, Morten</au><au>Nielsen, Henning K</au><au>Hansen, Klavs Würgler</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus</atitle><jtitle>Danish medical journal</jtitle><addtitle>Dan Med J</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>65</volume><issue>9</issue><eissn>2245-1919</eissn><abstract>The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipid-lowering treatment and to B) assess the validity of the DADD indicator as a measure of quality of care.
A) A pop-up questionnaire enquiring about reasons for lack of treatment was added to the clinicians' data entry tool in the Central Denmark Region. B) The DADD indicator was compared on a per-clinic basis with the achieved median low-density lipoprotein (LDL) cholesterol level and with an internationally widely used indicator of lipid-lowering treatment quality.
A) A total of 3,491 patients were registered from 1 January 2013 to 28 February 2015. For 170 (62%) of 309 patients with an LDL level > 2.5 mmol/l who were not receiving lipid-lowering treatment, there was no "good" explanation for lacking treatment. Among 518 patients with an LDL level > 2.5 mmol/l despite lipid-lowering treatment, 259 (50%) did not receive high-intensity treatment. B) The DADD quality indicator was neither associated with the international quality indicator nor with the median per-clinic LDL level for T2DM patients.
A) We found substantial potential for improvement of lipid management among T2DM patients in Denmark by initiating and/or intensifying lipid-lowering treatment. B) The current DADD indicator is not a valid measure of lipid-lowering quality of care.
supported by the Rosa and Asta Jensen Foundation.
not relevant.</abstract><cop>Denmark</cop><pmid>30187860</pmid></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2245-1919 |
| ispartof | Danish medical journal, 2018-09, Vol.65 (9) |
| issn | 2245-1919 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2100326745 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Aged Cholesterol, LDL - blood Denmark Diabetes Mellitus, Type 2 - complications Female Humans Hypercholesterolemia - drug therapy Hypolipidemic Agents - therapeutic use Male Middle Aged Quality Indicators, Health Care Retrospective Studies |
| title | Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A58%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimisation%20of%20quality%20indicators%20for%20lipid-lowering%20treatment%20of%20type%202%20diabetes%20mellitus&rft.jtitle=Danish%20medical%20journal&rft.au=Madsen,%20Michael%20Moesmann&rft.date=2018-09-01&rft.volume=65&rft.issue=9&rft.eissn=2245-1919&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2100326745%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2100326745&rft_id=info:pmid/30187860&rfr_iscdi=true |